Correlation Between Cellectis and Bellicum Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cellectis and Bellicum Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectis and Bellicum Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectis SA and Bellicum Pharmaceuticals, you can compare the effects of market volatilities on Cellectis and Bellicum Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectis with a short position of Bellicum Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectis and Bellicum Pharmaceuticals.
Diversification Opportunities for Cellectis and Bellicum Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cellectis and Bellicum is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and Bellicum Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellicum Pharmaceuticals and Cellectis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectis SA are associated (or correlated) with Bellicum Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellicum Pharmaceuticals has no effect on the direction of Cellectis i.e., Cellectis and Bellicum Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cellectis and Bellicum Pharmaceuticals
Given the investment horizon of 90 days Cellectis is expected to generate 14.22 times less return on investment than Bellicum Pharmaceuticals. But when comparing it to its historical volatility, Cellectis SA is 3.6 times less risky than Bellicum Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Bellicum Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 40.00 in Bellicum Pharmaceuticals on August 27, 2024 and sell it today you would lose (3.00) from holding Bellicum Pharmaceuticals or give up 7.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 6.62% |
| Values | Daily Returns |
Cellectis SA vs. Bellicum Pharmaceuticals
Performance |
| Timeline |
| Cellectis SA |
| Bellicum Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cellectis and Bellicum Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cellectis and Bellicum Pharmaceuticals
The main advantage of trading using opposite Cellectis and Bellicum Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectis position performs unexpectedly, Bellicum Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellicum Pharmaceuticals will offset losses from the drop in Bellicum Pharmaceuticals' long position.| Cellectis vs. Eliem Therapeutics | Cellectis vs. HCW Biologics | Cellectis vs. Scpharmaceuticals | Cellectis vs. Milestone Pharmaceuticals |
| Bellicum Pharmaceuticals vs. Cellectis SA | Bellicum Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Bellicum Pharmaceuticals vs. Atara Biotherapeutics | Bellicum Pharmaceuticals vs. Affimed NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |